Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	240.63M -5.3%
Revenue (ttm)	162.47M +12.4%
Net Income	2.36M -64.4%
EPS	0.22 -62.6%
Shares Out	10.07M
PE Ratio	106.50
Forward PE	30.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,680
Average Volume	1,512
Open	23.75
Previous Close	23.75
Day's Range	23.70 - 23.90
52-Week Range	21.80 - 26.50
Beta	0.63
RSI	46.76
Earnings Date	Apr 10, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 380
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.